A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
Clinical trial NCT07606599 · RECRUITING
Trial details
- NCT number
- NCT07606599
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-07
- Primary completion
- 2028-12-01
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.